Hillary Hubley

Associate

email
vCard

New York

Tel: +1 212 909 6035

Overview

Hillary Hubley is a litigation associate and a member of the firm’s White Collar and Regulatory Defense and International Dispute Resolution Groups. Ms. ... Read Full Biography

Publications

FCPA Update June 2024
1 July 2024

David A. O'Neil
,
Andrew M. Levine
,
Winston M. Paes
,
Jane Shvets
,
Douglas S. Zolkind
,
Carter Burwell
,
Philip Rohlik
,
Connor R. Crowley
,
Hillary Hubley
,
Zhiqi Wu
Bloomberg Law: SCOTUS Avoids Merits Ruling That Would Disrupt FDA Drug Reviews
17 June 2024

Bloomberg Law

Shannon Rose Selden
,
Hillary Hubley
,
Isabelle Canaan
DOJ National Security Division Issues First-Ever Declination Under Enforcement Policy
29 May 2024

Satish M. Kini
,
David A. O'Neil
,
Jane Shvets
,
Rick Sofield
,
Douglas S. Zolkind
,
Carter Burwell
,
Connor R. Crowley
,
Hillary Hubley

Upcoming Events

Recent Events

Hillary Hubley is a litigation associate and a member of the firm’s White Collar and Regulatory Defense and International Dispute Resolution Groups.Ms. Hubley was previously a member of the firm’s Financial Institutions Group where she focused on sanctions and anti-money laundering matters.Ms. Hubley joined Debevoise in 2021. She received her J.D. from Columbia Law School in 2021, where she was named a James Kent Scholar, Harlan Fiske Stone Scholar, and received the Parker School Certificate for Achievement in International and Comparative Law. Ms. Hubley received an LL.M., cum laude, in International Criminal Law from the University of Amsterdam in 2021, and a B.S., cum laude, from Northwestern University in 2015. Ms. Hubley is a co-author of “DOJ National Security Division Issues First-Ever Declination Under Enforcement Policy,” NYU PCCE (June, 2024) and “SCOTUS Avoids Merits Ruling That Would Disrupt FDA Drug Reviews,” Bloomberg Law (June, 2024). She is also the author of Bad Speech, Good Evidence: Content Moderation in the Context of Open-Source Investigations, International Criminal Law Review (2022).